Myxedema Coma Diagnostic Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
myxedema coma score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Unlikely0–24
  • Possible25–44
  • At Risk45–59
  • Diagnostic60–100
Direct Clinical Answer

The Myxedema Coma Diagnostic Score calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include body temperature. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Diagnostic scoring system for myxedema coma (MC), a rare but life-threatening decompensated state of extreme hypothyroidism. This validated scoring system facilitates early recognition and treatment by evaluating thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic dysfunction along with precipitating events.

Clinical Indication

The Myxedema Coma Diagnostic Score is indicated for bedside clinical practice to support Diagnostic scoring system for myxedema coma (MC), a rare but life-threatening decompensated state of extreme hypothyroidism. This validated scoring system facilitates early recognition and treatment by evaluating thermoregulatory, central nervous, cardiovascular, gastrointestinal, and metabolic dysfunction along with precipitating events.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.

Limitations & Contraindications

Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.

Clinical Pearls & Action Plan

Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: The scoring system has 100% sensitivity and 85.71% specificity at a cutoff score of 60.

Formula & Variables:

Myxedema Coma Score = Body Temperature Points + Central Nervous System Points + Cardiovascular Points + Gastrointestinal Points + Metabolic Points + Precipitating Event Points

Input Parameters

NameTypeRequiredDescription
body_temperaturestringYesCore body temperature reflecting thermoregulatory dysfunction in severe hypothyroidism
central_nervous_systemstringYesCentral nervous system manifestations of severe hypothyroidism affecting consciousness and neurological function
cardiovascular_dysfunctionstringYesCardiovascular manifestations including heart rate, blood pressure, and cardiac function abnormalities
gastrointestinal_dysfunctionstringYesGastrointestinal manifestations including constipation, ileus, and motility disorders
metabolic_dysfunctionstringYesMetabolic abnormalities including hyponatremia, hypoglycemia, and other electrolyte disturbances
precipitating_eventstringYesPresence of precipitating events that may trigger myxedema coma in patients with severe hypothyroidism

Score Interpretation & Guidance

RangeStageDescription
0–24UnlikelyMyxedema coma unlikely
25–44PossibleMyxedema coma possible but unlikely
45–59At RiskPatient at risk for myxedema coma
60–100DiagnosticHighly suggestive of myxedema coma

Evidence-Based References (EBM)

  • Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808-17. doi: 10.4158/EP13460.OR.DOI: 10.4158/EP13460.OR
  • Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, et al. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462. doi: 10.4061/2011/493462.DOI: 10.4061/2011/493462
  • Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Physician. 2000;62(11):2485-90.

Related calculators